Back
CVS Health Vs. Akero Therapeutics Industry Stock Comparison
Buy
66
CVS
CVS Health
Last Price:
$65.21
Seasonality Move:
5.24%
Sell
17
AKRO
Akero Therapeutics
Last Price:
$41.69
Seasonality Move:
-20.18%
Buy
66
CVS Health (CVS)
is a Buy
Is CVS Health a Buy, Sell or Hold?
-
The current CVS Health [CVS] share price is $66.33. The Score for CVS is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
CVS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
17
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $42.10. The Score for AKRO is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
-
AKRO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
CVS Stock Price Chart
What is CVS Health's stock price today?
-
The CVS Health share price today is $66.33The current trend is moderately bullish and CVS is experiencing buying pressure, which is a positive indicator for future bullish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $42.10Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.
CVS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.76 | Buy |
Relative Strength Index (14 RSI): | 66.87 | Buy |
Chaikin Money Flow: | 3921404 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (56.85 - 66.29) | Buy |
Bollinger Bands (100): | (49.42 - 62.66) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.46 | Buy |
Relative Strength Index (14 RSI): | 40.45 | Sell |
Chaikin Money Flow: | -857514 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (46.09 - 54.09) | Sell |
Bollinger Bands (100): | (25.41 - 45.17) | Buy |
CVS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 65.09 | Buy |
20-day SMA: | 62.89 | Buy |
50-day SMA: | 55.41 | Buy |
200-day SMA: | 57.46 | Buy |
8-day EMA: | 65.13 | Buy |
20-day EMA: | 62.87 | Buy |
50-day EMA: | 58.8 | Buy |
200-day EMA: | 59.12 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 45.7 | Sell |
20-day SMA: | 48.75 | Sell |
50-day SMA: | 39.78 | Buy |
200-day SMA: | 30.05 | Buy |
8-day EMA: | 45.32 | Sell |
20-day EMA: | 46.41 | Sell |
50-day EMA: | 42.22 | Sell |
200-day EMA: | 33.02 | Buy |
CVS Health Earnings Growth & CVS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.16 per share, an increase next quarter of $0.17 per share, an increase this year of $0.72 per share, and an increase next year of $0.94 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and a decrease next year of $0.63 per share.
CVS Health Technical Analysis
Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
21 | 25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
21 | 25 | 26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |